Manufacturing Quality Control for Plasmid DNA Critical Starting Materials
Andrew Frazer, Lauren R. Salvitti
Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing
K Bruce, K Bharti, I Barbaric et al
Next-generation sequencing in adventitious agent testing: navigating regulatory acceptance
Olaf Stamm, Horst Ruppach, Minu Youngkin
Achieving rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study
M Dingle, A Carwell, M J. Miller et al
Fit-for-purpose analytical development for an emerging cell therapy landscape
J Wei, D Rill, F Durst et al
Transforming viral vector manufacturing with next-generation CGMP plasmids platform
John Bowen, Brian Tomkowicz
Cost reduction of viral vector processes using 3D nanofiber-based cell culture systems in upstream bioprocessing
Rob Noel, Geddy Hamblen, Christel Fenge
Strategies for streamlined manufacturing and analytics in CGT development
Laura Mueller, Silvio Weber, Dirk Windgassen
Producing MSC-derived cell therapies: workflows, technologies, and case studies
I Malaspina, S Mei, T Ting et al
28 March 2025
Expert Roundtable
Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells
Mindy Miller, Nathan Frank
Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes
Marc Struhalla, Svenja Michalek
26 March 2025
Innovator Insight
Efficient AAV purification: resin reuse and scalable polish method
Nicolas Laroudie, Duncan Dulac
Transforming cell therapy manufacturing: smart automation & genetic modification for scalable success
Peter Szaraz, Tessel Hammink
Industrialization of AAV manufacturing with Xcite® transient and stable production platforms
Suparna Sanyal, Peng Wang
GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing
Lili Belcastro, Basak Clements, Claire Wartel